ACHVAchieve Life Sciences, Inc.

$227M

Q2 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$10M

Net Income

-$10M

EPS (Diluted)

$-1.13

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$8M

Free Cash Flow

-$8M

Stock-Based Comp.

$840,000

Balance Sheet

Total Assets

$34M

Total Liabilities

$21M

Stockholders' Equity

$13M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$10M	-$11M	+10.9%
Net Income	-$10M	-$11M	+7.5%

ACHV Q2 2022 Earnings — Achieve Life Sciences, Inc. Revenue & Financial Results | Market Cap Arena